Why Akero Therapeutics Stock Trounced the Market on Thursday

Key Points It agreed to be acquired by a high-profile pharmaceutical company. The buyout could be worth as much as $5.2 billion. 10 stocks we like better than Akero Therapeutics › One of the best catalysts for sudden, sharp rise in the price of a stock is when the company behind it get acquired at a premium. Case in point: Akero Therapeutics (NASDAQ: AKRO), whose shares soared by more than 16% Thursday after it was revealed the biotech will have a new owner. That pop was especially impressive, give ...